Literature DB >> 20593419

Mice lacking the orphan receptor ror1 have distinct skeletal abnormalities and are growth retarded.

Natalia Lyashenko1, Martina Weissenböck, Amnon Sharir, Reinhold G Erben, Yasuhiro Minami, Christine Hartmann.   

Abstract

Ror1 is a member of the Ror-family receptor tyrosine kinases. Ror1 is broadly expressed in various tissues and organs during mouse embryonic development. However, so far little is known about its function. The closely related family member Ror2 was shown to play a crucial role in skeletogenesis and has been shown to act as a co-receptor for Wnt5a mediating non-canonical Wnt-signaling. Previously, it has been shown that during embryonic development Ror1 acts in part redundantly with Ror2 in the skeletal and cardiovascular systems. In this study, we report that loss of the orphan receptor Ror1 results in a variety of phenotypic defects within the skeletal and urogenital systems and that Ror1 mutant mice display a postnatal growth retardation phenotype.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20593419     DOI: 10.1002/dvdy.22362

Source DB:  PubMed          Journal:  Dev Dyn        ISSN: 1058-8388            Impact factor:   3.780


  13 in total

1.  Mouse resistin modulates adipogenesis and glucose uptake in 3T3-L1 preadipocytes through the ROR1 receptor.

Authors:  Beatriz Sánchez-Solana; Jorge Laborda; Victoriano Baladrón
Journal:  Mol Endocrinol       Date:  2011-11-10

Review 2.  The role of Ryk and Ror receptor tyrosine kinases in Wnt signal transduction.

Authors:  Jennifer Green; Roel Nusse; Renée van Amerongen
Journal:  Cold Spring Harb Perspect Biol       Date:  2014-02-01       Impact factor: 10.005

3.  Wnt5a-Ror-Dishevelled signaling constitutes a core developmental pathway that controls tissue morphogenesis.

Authors:  Hsin-Yi Henry Ho; Michael W Susman; Jay B Bikoff; Yun Kyoung Ryu; Andrea M Jonas; Linda Hu; Rejji Kuruvilla; Michael Eldon Greenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-17       Impact factor: 11.205

4.  Appropriate crypt formation in the uterus for embryo homing and implantation requires Wnt5a-ROR signaling.

Authors:  Jeeyeon Cha; Amanda Bartos; Craig Park; Xiaofei Sun; Yingju Li; Sang-Wook Cha; Rieko Ajima; Hsin-Yi Henry Ho; Terry P Yamaguchi; Sudhansu K Dey
Journal:  Cell Rep       Date:  2014-07-17       Impact factor: 9.423

5.  Wnt5a induces ROR1/ROR2 heterooligomerization to enhance leukemia chemotaxis and proliferation.

Authors:  Jian Yu; Liguang Chen; Bing Cui; George F Widhopf; Zhouxin Shen; Rongrong Wu; Ling Zhang; Suping Zhang; Steven P Briggs; Thomas J Kipps
Journal:  J Clin Invest       Date:  2016-02       Impact factor: 14.808

Review 6.  WNT signaling in bone homeostasis and disease: from human mutations to treatments.

Authors:  Roland Baron; Michaela Kneissel
Journal:  Nat Med       Date:  2013-02-06       Impact factor: 53.440

Review 7.  Nuclear receptors in bone physiology and diseases.

Authors:  Yuuki Imai; Min-Young Youn; Kazuki Inoue; Ichiro Takada; Alexander Kouzmenko; Shigeaki Kato
Journal:  Physiol Rev       Date:  2013-04       Impact factor: 37.312

8.  Non-canonical Wnt5a/Ror2 signaling regulates kidney morphogenesis by controlling intermediate mesoderm extension.

Authors:  Kangsun Yun; Rieko Ajima; Nirmala Sharma; Frank Costantini; Susan Mackem; Mark Lewandoski; Terry P Yamaguchi; Alan O Perantoni
Journal:  Hum Mol Genet       Date:  2014-07-31       Impact factor: 6.150

9.  ROR1 can interact with TCL1 and enhance leukemogenesis in Eμ-TCL1 transgenic mice.

Authors:  George F Widhopf; Bing Cui; Emanuela M Ghia; Liguang Chen; Karen Messer; Zhouxin Shen; Steven P Briggs; Carlo M Croce; Thomas J Kipps
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-30       Impact factor: 11.205

10.  ROR1 and ROR2 in Human Malignancies: Potentials for Targeted Therapy.

Authors:  Guilly Rebagay; Su Yan; Cheng Liu; Nai-Kong Cheung
Journal:  Front Oncol       Date:  2012-04-18       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.